Concepedia

Qiuxiang Wang

QW

Statistics

Publications

7

Citations

518

H-Index

7

Active since

2018

Affiliations

Tongji Hospital(Current)

Huazhong University of Science and Technology

Wuhan University of Science and Technology

Affiliated Hospital of Nantong University

Nantong University

Qiuxiang Wang is an author at Tongji Hospital specializing in chimeric antigen receptor t-cell therapy, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2018–2025

7

Publications

7

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies

Na Wang, Xuelian Hu, Wenyue Cao et al. · Blood · 2019 · 264 citations · Full text

, , +12

A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia

Chunrui Li, Wenyue Cao, Yimei Que et al. · Clinical and Translational Medicine · 2021 · 69 citations · Full text

, , +16

Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma

Jinhuan Xu, Qiuxiang Wang, Hao Xu et al. · Journal of Hematology & Oncology · 2018 · 62 citations · Full text

, , +16

γ-Cyclodextrin-based polypseudorotaxane hydrogels for ophthalmic delivery of flurbiprofen to treat anterior uveitis

Guihua Fang, Qiuxiang Wang, Xuewen Yang et al. · Carbohydrate Polymers · 2021 · 48 citations

, , +16

T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies

Chunrui Li, Qiuxiang Wang, Hui Zhu et al. · Blood · 2018 · 45 citations

, , +12

1–5 of 7